Diagnostic Medical Reports Q3 2026 Revenue of EUR 7.9 Million Amidst Declining Radiology Sales

Diagnostic Medical Systems Group (DMS) reported a Q3 2026 revenue of EUR 7.9 million, a 28% drop from Q3 2025. The decline is attributed to a decrease in Radiology revenue due to challenging economic conditions in Europe and Middle East conflicts. Revenues from Radiology fell 44% in Q3 2026, but Bone Densitometry saw a 34% increase.

European markets, particularly in France and Italy, have experienced slowed decision-making and project delays. However, the Americas showed promising growth, particularly in South America with robust orders, indicating diversified revenue sources.

DMS Group maintains its focus on improving profitability through operational efficiency. With a weakened economic environment, the company reaffirms its 2026 EBITDA target of 14%.